Clinical Trial Update: Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating atezolizumab before surgery in regionally metastatic head and neck cutaneous squamous cell carcinoma; the study is terminated wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma of the Head and Neck
• Cutaneous Squamous Cell Carcinoma of the Head and Neck Ajcc V8
• Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Arnaud Bewley, MD | Conditions: Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Status: TERMINATED | Results posted: 2023-09-05